241 – 250 of 316
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with l-DOPA: Relation to dose and route of administration.
(
- Contribution to journal › Article
-
Mark
Tracking the neurodegeneration of parkinsonian disorders - A pilot study
(
- Contribution to journal › Article
-
Mark
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
(
- Contribution to journal › Article
-
Mark
Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion
(
- Contribution to journal › Article
-
Mark
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
(
- Contribution to journal › Article
- 2006
-
Mark
Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
(
- Contribution to journal › Article
-
Mark
Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.
(
- Contribution to journal › Article